首页> 中文期刊> 《中国卫生产业 》 >肝门部胆管癌致梗阻性黄疸介入引流治疗效果评价

肝门部胆管癌致梗阻性黄疸介入引流治疗效果评价

             

摘要

Objective Of hilar cholangiocarcinoma with obstructive jaundice caused by interventional drainage treatment effect were discussed and analyzed.Methods A retrospective analysis was conducted from 2009 October to 2013 in our hospital during October were caused by extraction of hilar bile duct carcinoma in patients with obstructive jaundice in 68 patients, all patients underwent percutaneous drainage and biliary stent implantation in the treatment of patients in the operation, after 1 months test indicators of liver function of statistics, and compare the liver function before operation. Results After treatment, compared with before operation, all patients with TBIL (serum total bilirubin) decreased by more than 30%, the total effective rate was 94.1%(64/68), jaundice and the removal rate reached 86.8%(59/68). In TBIL, ALT(alanine aminotransferase), SGOT (AST) and other indexes of liver function,postoperative drainage were significantly lower than those before operation ( P<0.05).Conclusion For patients with obstructive jaundice caused by hilar cholangiocarcinoma,implementation of percutaneous drainage and biliary stent placement treatment can play a better effect, the jaundice eased, liver function improved,has important clinical value in use.%目的:对肝门部胆管癌致梗阻性黄疸介入引流治疗的效果进行探讨与分析。方法从我院2009年10月-2013年10月期间收治的肝门部胆管癌致梗阻性黄疸患者中抽取68例进行回顾性分析,所有患者均实施经皮介入引流术+胆道支架置入术治疗,对患者术后1个月当中肝功能化验指标进行统计,并对比术前肝功能指标。结果手术前后相比,所有患者TBIL(血清总胆红素)降低30%以上,总有效率达到了94.1%(64/68),黄疸消除率达到了86.8%(59/68)。在TBIL、ALT(谷丙转氨酶)、SGOT(谷草转氨酶)等肝功能指标上,术后要显著低于术前(P<0.05)。结论对于肝门部胆管癌致梗阻性黄疸患者来说,实施经皮介入引流术+胆道支架置入术治疗能起到较好效果,使黄疸得到减轻,肝功能得到明显改善,有着重要临床使用价值。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号